Bhageria Industries Reports Robust Q2 and H1 FY26 Standalone & Consolidated Financial Results
Bhageria Industries reported strong Q2 and H1 FY26 standalone and consolidated financial results. Revenue and profit saw significant year-on-year growth, driven primarily by the Chemicals segment.
The announcement of significantly improved quarterly and half-yearly financial results, with strong growth in both revenue and profit, is a major positive indicator for the company's performance and is likely to have a high impact on investor perception.
Both standalone and consolidated financial results show substantial year-on-year growth in revenue and profit for the quarter and half-year ended September 30, 2025. This indicates strong operational performance.
Bhageria Industries Limited announced the un-audited standalone and consolidated financial results for the quarter and half-year ended September 30, 2025, approved by its Board of Directors on October 18, 2025. The statutory auditors have conducted a "Limited Review" of these results.
* Standalone Financial Highlights (Quarter ended September 30, 2025): * Revenue from operations stood at ₹20,475.47 lakhs, a significant increase from ₹12,937.03 lakhs in the corresponding quarter of the previous year. * Profit for the period was ₹1,218.55 lakhs, up from ₹672.69 lakhs in Q2 FY25. * Basic Earnings Per Share (EPS) increased to ₹2.79 from ₹1.54 in Q2 FY25.
* Standalone Financial Highlights (Half-year ended September 30, 2025): * Revenue from operations reached ₹36,275.85 lakhs, compared to ₹24,189.53 lakhs in H1 FY25. * Profit for the period was ₹2,417.69 lakhs, a substantial rise from ₹1,281.54 lakhs in H1 FY25. * Basic EPS for the half-year improved to ₹5.54 from ₹2.94 in H1 FY25.
* Consolidated Financial Highlights (Quarter ended September 30, 2025): * Revenue from operations was ₹20,438.51 lakhs, up from ₹12,910.61 lakhs in Q2 FY25. * Profit for the period was ₹1,147.29 lakhs, compared to ₹638.51 lakhs in Q2 FY25. * Basic EPS increased to ₹2.70 from ₹1.50 in Q2 FY25.
* Consolidated Financial Highlights (Half-year ended September 30, 2025): * Revenue from operations was ₹36,186.88 lakhs, up from ₹24,163.11 lakhs in H1 FY25. * Profit for the period was ₹2,235.55 lakhs, compared to ₹1,219.74 lakhs in H1 FY25. * Basic EPS for the half-year improved to ₹5.28 from ₹2.86 in H1 FY25.
* Segment-wise Standalone Performance (Half-year ended September 30, 2025): * The Chemicals segment reported revenue of ₹34,425.18 lakhs (H1 FY25: ₹20,568.72 lakhs) and a profit of ₹3,486.14 lakhs (H1 FY25: ₹1,204.82 lakhs). * Solar Power segment revenue was ₹1,152.73 lakhs (H1 FY25: ₹1,263.81 lakhs) with a profit of ₹475.67 lakhs (H1 FY25: ₹420.01 lakhs). * The Pharma segment generated revenue of ₹265.66 lakhs (H1 FY25: ₹84.16 lakhs) but reported a loss of ₹(272.61) lakhs (H1 FY25: ₹(146.73) lakhs).
The full financial results will be available on the websites of NSE, BSE, and the company.
What to do with a filing like this
Bhageria Industries Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Bhageria Industries Limited. Read the original for the full detail.